↑ 薬物リストへ　← 戻る

Ursofalk® 500 mg filmtabletten    (DrugBank: -)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
93原発性胆汁性胆管炎［原発性胆汁性肝硬変 (~2017.3)］1

93. 原発性胆汁性胆管炎［原発性胆汁性肝硬変 (~2017.3)］　［臨床試験数：230，薬物数：215（DrugBank：51），標的遺伝子数：34，標的パスウェイ数：107］
Searched query = "Primary biliary cholangitis", "Primary biliary cirrhosis", "PBC"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 230 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2006-003712-22-DE
(EUCTR)		23/10/200618/09/2006Pharmacokinetics of UDCA in serum and bile in patients with early stage PBC (stage I-III) and in healthy volunteersPharmacokinetics of UDCA in serum and bile in patients with early stage PBC (stage I-III) and in healthy volunteers Primary Biliary Cirrhosis Stage I-III
MedDRA version: 12.1;Level: LLT;Classification code 10036680;Term: Primary biliary cirrhosis		Trade Name: Ursofalk® 500 mg Filmtabletten
Product Name: Ursofalk® 500 mg Filmtabletten
INN or Proposed INN: Ursodeoxycholic acid		Dr. Falk Pharma GmbHNULLNot RecruitingFemale: yes
Male: yes		24Germany